Therapy Drives Genomic Evolution in Metastatic Cancer

0 views

|

April 12, 2023

  • Share
  • Oncotarget published this trending editorial on March 21, 2023 in Volume 14, entitled, “Therapy drives genomic evolution in metastatic cancer" by researchers from the Department of Clinical Medicine, Aarhus University, Aarhus 8200, Denmark; Department of Molecular Medicine, Aarhus University Hospital, Aarhus 8200, Denmark; Bioinformatics Research Center, Aarhus University, Aarhus 8000, Denmark. DOI - https://doi.org/10.18632/oncotarget.28379 (PDF) Correspondence to - Nicolai J. Birkbak - nbirkbak@clin.au.dk Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28379 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer evolution, metastatic cancer mutations, treatment-induced mutations, GENIE About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer ResearchCell Science

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.